Synthesis and evaluation of new hydrazide derivatives as neuropeptide Y Y5 receptor antagonists for the treatment of obesity

Add time:07/16/2019    Source:sciencedirect.com

NPY is the most potent orexigenic agent known to man, with NPY Y1 and NPY Y5 being the receptor subtypes that are most likely responsible for centrally-mediated NPY-induced feeding responses. Based on the aforementioned, novel hydrazide derivatives were prepared for the purpose of searching new NPY Y5 receptor antagonists. Many of the compounds exhibited nanomolar binding affinity for this receptor, affording trans-N-{4-[N′-(3,4-dichlorophenyl)hydrazinocarbonyl]cyclohexylmethyl}-4-fluorobenzenesulfonamide, which showed the best activity (IC50=0.43 nM).

We also recommend Trading Suppliers and Manufacturers of CYCLOHEXANECARBOXYLIC ACID HYDRAZIDE (cas 38941-47-8). Pls Click Website Link as below: cas 38941-47-8 suppliers

Prev:Biosynthesis of phoslactomycins: cyclohexanecarboxylic acid as the starter unit
Next:(R)-N-Methyl-3-(3-125I-pyridin-2-yloxy)-3-phenylpropan-1-amine: a novel probe for norepinephrine transporters)